NASHVILLE, Tenn., Feb. 15, 2011/PRNewswire/ -- Emdeon Inc. (NYSE: EM), one of the largest health information networks in the nation focusing on clinical exchange and a leading provider of healthcare revenue and payment cycle management solutions, today announced a strategic alliance with LabCorp (NYSE: LH) to deliver a co-branded Electronic Health Record (EHR) Lite solution to physician practices nationwide.
The Emdeon-LabCorp EHR Lite solution consists of Emdeon Clinician as an integrated module within Emdeon Office Suite, which is an easy-to-use web-based application that simplifies everyday administrative and clinical processes for healthcare providers. Emdeon Clinician, a component of Emdeon Office Suite, has been certified to meet Stage 1 Certification Criteria for Meaningful Use of EHR Technology by the Drummond Group Inc., an ONC-ATCB certifying body. Emdeon Office Suite enables unlimited eligibility and benefits verification, claims and payment management, electronic prescribing, patient billing and payment information and electronic access to LabCorp's clinical laboratory orders and results. This combined suite of clinical, financial and administrative capabilities is accessible via one simple, single sign-on portal.
"The Emdeon Office Suite with integrated LabCorp test ordering and results data gives healthcare providers a low cost, cloud-based solution," said Miriam Paramore, senior vice president of clinical and government services for Emdeon. "This technology streamlines clinical messaging designed to improve patient safety while helping providers qualify for federal HITECH stimulus dollars without unnecessary disruption and expense."
Meaningful Use criterion under the HITECH provisions of the American Recovery and Reinvestment Act (ARRA) requires healthcare providers to successfully capture and exchange electronic clinical healthcare information, such as electronic prescriptions and lab orders, to receive incentives and avoid penalties in payments from Medicare and Medicaid. The Emdeon Office Suite integrates with other practice management software, allowing providers to link-in their patient demographic and insurance data. It is also compatible with comprehensive EHR systems and supports bi-directional clinical information exchange.
Together, the Emdeon and LabCorp strategic alliance connects healthcare providers to a broad health information network with connectivity to all LabCorp facilities, as well as more than 125 additional labs, 5,000 hospitals, 60,000 pharmacies and 1,200 payers.
Emdeon will be demonstrating the Emdeon-LabCorp EHR Lite solution at booth number 2201 at the Healthcare Information and Management Systems Society (HIMSS) national conference in Orlando, February 20-24, 2011. More information as well as the schedule for speaking engagements can be found online at http://www.emdeon.com/HIMSS11/.
This complete EHR is 2011/2012 compliant and has been certified by an ONC-ATCB in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services or guarantee the receipt of incentive payments. Emdeon Inc, 10/22/10, Emdeon Clinician 7.4, 1014201030691, NQF0064/PQRI128, NQF0041/PQRI110, NQF0024, NQF0028, NQF0038, NQF0059/PQRI1, NQF0064/PQRI2, NQF0061/PQRI3.
Emdeon is a leading provider of revenue and payment cycle management solutions, connecting payers, providers and patients in the U.S. healthcare system. Emdeon's product and service offerings integrate and automate key business and administrative functions of its payer and provider customers throughout the patient encounter. Through the use of Emdeon's comprehensive suite of products and services, which are designed to easily integrate with existing technology infrastructures, customers are able to improve efficiency, reduce costs, increase cash flow and more efficiently manage the complex revenue and payment cycle process. For more information, visit www.emdeon.com.
Statements made in this press release that express Emdeon's or management's intentions, plans, beliefs, expectations or predictions of future events are forward-looking statements, which Emdeon intends to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. These statements often include words such as "may," "will," "should," "believe," "expect," "anticipate," "intend," "plan," "estimate" or similar expressions. Forward-looking statements also may include information concerning Emdeon's possible or assumed future results of operations, including descriptions of Emdeon's revenues, profitability and outlook and its overall business strategy. You should not place undue reliance on these statements because they are subject to numerous uncertainties and factors relating to Emdeon's operations and business environment, all of which are difficult to predict and many of which are beyond Emdeon's control. Although Emdeon believes that these forward-looking statements are based on reasonable assumptions, you should be aware that many factors could affect Emdeon's actual financial results or results of operations and could cause actual results to differ materially from those in the forward-looking statements, including the risks discussed in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections and elsewhere in Emdeon's Annual Report on Form 10-K for the year ended December 31, 2009, as well as Emdeon's periodic and other reports, filed with the Securities and Exchange Commission.
You should keep in mind that any forward-looking statement made by Emdeon herein, or elsewhere, speaks only as of the date on which made. Emdeon expressly disclaims any intent, obligation or undertaking to update or revise any forward-looking statements made herein to reflect any change in Emdeon's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.
SOURCE Emdeon Inc.